Aligos Therapeutics, Inc. (ALGS) — research page
US · us-cm-kg/NASDAQ/ALGS · as of 2026-11-08
Identity and listing
The issuer is Aligos Therapeutics, Inc., listed on NASDAQ under ticker ALGS, ISIN US01626L2043, LEI 549300UU2UJIKJYX0S67. Its security type is Corporate. Its segment is not on the record. Its sector is 2836 Biological Products, (No Diagnostic Substances), and its jurisdiction is United States — Delaware. Its listing status is listed, not halted.
| field | value | source · read date |
|---|---|---|
| name | Aligos Therapeutics, Inc. | source · 2026-11-08 |
| exchange | NASDAQ | source · 2026-11-08 |
| ticker | ALGS | source · 2026-11-08 |
| ISIN | US01626L2043 | source · 2026-11-08 |
| LEI | 549300UU2UJIKJYX0S67 | source · 2026-11-08 |
| security type | Corporate | source · 2026-11-08 |
| segment | not on the record | |
| sector | 2836 Biological Products, (No Diagnostic Substances) | source · 2026-11-08 |
| jurisdiction | United States — Delaware | source · 2026-11-08 |
| status | listed, not halted | source · 2026-11-08 |
The disclosure read
The record holds 35 filings across 18 filing days in the twelve months to 2026-11-08. The median gap between filing days is 8 days. The latest filing is dated 2026-11-06, a results filing, 2 days before the record date. The exchange median gap is 6.0 days across 4359 issuers, and the sector median gap is 5.5 days across 176 issuers. The exchange median is 52 filings and the sector median is 65.5 filings. The exchange median latency is 5.0 days and the sector median latency is 4.0 days. The issuer's 35 filings are below the exchange median of 52 and below the sector median of 65.5. By type, the window holds 11 directors' dealings, 9 regulatory filings, 8 results, 3 corporate news, 2 AGM/EGM and 2 director changes.
| filings | median gap between filing days | days from latest filing to as-of | |
|---|---|---|---|
| this issuer | 35 | 8 | 2 |
| exchange median: NASDAQ (4359 issuers) | 52 | 6 | 5 |
| sector median: 2836 Biological Products, (No Diagnostic Substances) (176 issuers) | 65.5 | 5.5 | 4 |
| date | type | category | filing |
|---|---|---|---|
| 2026-11-06 | results | 10-Q | 10-Q — 10-Q |
| 2026-11-06 | results | 8-K | 8-K — FORM 8-K (items 2.02,9.01) |
| 2026-09-15 | corporate_news | 8-K | 8-K — 8-K (items 1.01) |
| 2026-08-06 | regulatory_filing | S-8 | S-8 — S-8 |
| 2026-08-06 | results | 10-Q | 10-Q — 10-Q |
window 2025-11-08 to 2026-11-08 · the node's disclosure lines, as get_filings serves them
Auditor
The auditor of record is Ernst & Young LLP, located in San Francisco, California. The record holds no auditor changes.
Events and halts
The record holds no listing, delisting, name change or segment move lines. Domicile change is not on the record, as EDGAR states no dated change of state of incorporation on a filing line. Segment move is not on the record, as the exchanges' tier transfers are not EDGAR filings. The halt flag reads listed, not halted.
Orderability
The outcome is not determinable. The chapter's orderability section carries no client categories, so the outcome cannot name its client category. The rule version is acm-68000/us/reasonable-basis-suitability-finra-rule-2111/r1, and the chapter is as of 2026-11-04.
rule acm-68000/us/reasonable-basis-suitability-finra-rule-2111/r1 · chapter as of 2026-11-04 · the full outcome: get_orderability
Coverage
No research houses were found on the issuer's investor-relations page.
Open research
No openly published research notes were found on the record.
Licensed
Licensed research: none loaded. A licensed row is served only to an agent whose firm holds that licence (licensor, entitlement). No licensed row is loaded.
| licensor | entitlement | title | date | source |
|---|---|---|---|---|
| none loaded |
As-of depth
The vintage is sealed. The issuer's sealed years are 2021, 2022, 2023, 2024, 2025 and 2026. The market's earliest sealed date is 2021-01-04. The live record began on 2026-09-12.
Sources
9 source pages are named on this page; every value above carries its own source page and read date in the numbers.
- 10.1
- https://www.sec.gov/files/company_tickers_exchange.json (identity.exchange)
- 10.2
- https://mapping.gleif.org/api/v2/isin-lei/latest (identity.isin)
- 10.3
- https://data.sec.gov/submissions/CIK0001799448.json (identity.jurisdiction)
- 10.4
- https://mapping.gleif.org/api/v2/isin-lei/latest/download (identity.lei)
- 10.5
- https://mcp.us-cm-kg.ai/events/NASDAQ/ALGS (the disclosure lines)
- 10.6
- https://www.nasdaqtrader.com/rss.aspx?feed=tradehalts (the halt flag)
- 10.7
- https://www.sec.gov/Archives/edgar/data/1799448/000119312526092614/algs-20251231.htm (the auditor)
- 10.8
- https://mcp.us-cm-kg.ai/book/aio.json (the orderability chapter)
- 10.9
- https://mcp.us-cm-kg.ai/record/NASDAQ/ALGS (the record)
Read it by agent
The same page, signed and receipted: get_research at https://mcp.getissuer.ai/mcp with {"isin":"US01626L2043"}. Twins: .md · .json. Written: Claude through the platform account, Haiku class; one pass; checked against the numbers. Page hash sha256:f8d8f75fe787c117.